Peter Mullany
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 18
- Periodontics top 0.5%
- Oral microbiology and periodontitis research 24
- Infectious Diseases top 0.5%
- Clostridium difficile and Clostridium perfringens research 45
- Antimicrobial Resistance in Staphylococcus 27
- Viral gastroenteritis research and epidemiology 21
- Endocrinology top 1%
-
- Bacteriophages and microbial interactions 25
-
- Gut microbiota and health 12
- Genomics and Phylogenetic Studies 9
- Co-authors
- Adam P. RobertsDik MeviusH.J.M. AartsAngela H. A. M. van HoekBeatriz GuerraElaine AllanMichael A. WilsonHaitham Hussain
- Journals
- Antimicrobial Agents and Chemotherapy (11 papers)Journal of Bacteriology (9 papers)Journal of Antimicrobial Chemotherapy (6 papers)
- Partner nations
- United KingdomAustraliaNetherlands
In The Last Decade
Peter Mullany
108 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Molecular Medicine 1.0k
- Periodontics 583
- Infectious Diseases 1.8k
- Endocrinology 373
- Applied Microbiology and Biotechnology 128
Countries citing papers authored by Peter Mullany
This map shows the geographic impact of Peter Mullany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mullany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mullany more than expected).
Fields of papers citing papers by Peter Mullany
This network shows the impact of papers produced by Peter Mullany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mullany. The network helps show where Peter Mullany may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Mullany, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 20 | |
| 2 | 2020 | 62 | |
| 3 | 2020 | 58 | |
| 4 | 2013 | 41 | |
| 5 | 2012 | 10 | |
| 6 | 2011 | 78 | |
| 7 | 2011 | 176 | |
| 8 | Acquired Antibiotic Resistance Genes: An Overviewbreakdown → | 2011 | 891 |
| 9 | 2005 | 53 | |
| 10 | 2004 | 12 | |
| 11 | 2003 | 85 | |
| 12 | 2003 | 19 | |
| 13 | 2002 | 23 | |
| 14 | 2001 | 35 | |
| 15 | 2000 | 32 | |
| 16 | 1999 | 107 | |
| 17 | 1996 | 62 | |
| 18 | 1995 | 1 | |
| 19 | 1987 | 1 | |
| 20 | MOLECULAR-CLONING AND EXPRESSION OF CLOSTRIDIUM-DIFFICILE TOXIN-A IN ESCHERICHIA-COLI K-12 | 1987 | 1 |
About Peter Mullany
Peter Mullany is a scholar working on Periodontics, Molecular Medicine, Infectious Diseases, Endocrinology and Applied Microbiology and Biotechnology, having authored 112 papers that have together received 4.8k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (45 papers), Antimicrobial Resistance in Staphylococcus (27 papers), Bacteriophages and microbial interactions (25 papers), Oral microbiology and periodontitis research (24 papers), Viral gastroenteritis research and epidemiology (21 papers), Antibiotic Resistance in Bacteria (18 papers), Gut microbiota and health (12 papers) and Genomics and Phylogenetic Studies (9 papers). The work is most often cited by research in Molecular Medicine (1.0k citations), Periodontics (583 citations), Infectious Diseases (1.8k citations), Endocrinology (373 citations) and Applied Microbiology and Biotechnology (128 citations). Peter Mullany has collaborated with scholars based in United Kingdom, Australia and Netherlands. Frequent co-authors include Adam P. Roberts, Dik Mevius, H.J.M. Aarts, Angela H. A. M. van Hoek, Beatriz Guerra, Elaine Allan, Michael A. Wilson, Haitham Hussain, S. Tabaqchali and Michael S. M. Brouwer. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Bacteriology, Journal of Antimicrobial Chemotherapy, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.